| Style | Citing Format |
|---|---|
| MLA | Tanhaian A, et al.. "In Silico and in Vitro Investigation of a Likely Pathway for Anti-Cancerous Effect of Thrombocidin-1 As a Novel Anticancer Peptide." Protein and Peptide Letters, vol. 27, no. 8, 2020, pp. 751-762. |
| APA | Tanhaian A, Mohammadi E, Vakilighartavol R, Saberi MR, Mirzayi M, Jaafari MR (2020). In Silico and in Vitro Investigation of a Likely Pathway for Anti-Cancerous Effect of Thrombocidin-1 As a Novel Anticancer Peptide. Protein and Peptide Letters, 27(8), 751-762. |
| Chicago | Tanhaian A, Mohammadi E, Vakilighartavol R, Saberi MR, Mirzayi M, Jaafari MR. "In Silico and in Vitro Investigation of a Likely Pathway for Anti-Cancerous Effect of Thrombocidin-1 As a Novel Anticancer Peptide." Protein and Peptide Letters 27, no. 8 (2020): 751-762. |
| Harvard | Tanhaian A et al. (2020) 'In Silico and in Vitro Investigation of a Likely Pathway for Anti-Cancerous Effect of Thrombocidin-1 As a Novel Anticancer Peptide', Protein and Peptide Letters, 27(8), pp. 751-762. |
| Vancouver | Tanhaian A, Mohammadi E, Vakilighartavol R, Saberi MR, Mirzayi M, Jaafari MR. In Silico and in Vitro Investigation of a Likely Pathway for Anti-Cancerous Effect of Thrombocidin-1 As a Novel Anticancer Peptide. Protein and Peptide Letters. 2020;27(8):751-762. |
| BibTex | @article{ author = {Tanhaian A and Mohammadi E and Vakilighartavol R and Saberi MR and Mirzayi M and Jaafari MR}, title = {In Silico and in Vitro Investigation of a Likely Pathway for Anti-Cancerous Effect of Thrombocidin-1 As a Novel Anticancer Peptide}, journal = {Protein and Peptide Letters}, volume = {27}, number = {8}, pages = {751-762}, year = {2020} } |
| RIS | TY - JOUR AU - Tanhaian A AU - Mohammadi E AU - Vakilighartavol R AU - Saberi MR AU - Mirzayi M AU - Jaafari MR TI - In Silico and in Vitro Investigation of a Likely Pathway for Anti-Cancerous Effect of Thrombocidin-1 As a Novel Anticancer Peptide JO - Protein and Peptide Letters VL - 27 IS - 8 SP - 751 EP - 762 PY - 2020 ER - |